Crispr gene editing concept

CRISPR-Cas9 gene editing has revolutionized biotechnology, enabling precise DNA modifications with applications in medicine, agriculture, and research.

About this subject

CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, is a gene editing technology inspired by a bacterial defense mechanism. Developed by scientists Emmanuelle Charpentier and Jennifer Doudna, the system uses the Cas9 enzyme guided by RNA to cut DNA at specific locations, allowing genes to be inserted, removed, or modified. The discovery won the Nobel Prize in Chemistry in 2020.

In medicine, CRISPR is being tested in clinical trials for diseases such as sickle cell disease, beta-thalassemia, and certain cancers. In 2023, the United Kingdom approved Casgevy, the first CRISPR-based treatment for sickle cell disease and beta-thalassemia. In agriculture, genetically edited crop varieties like soybean and corn for pest resistance or drought tolerance are under development in Brazil, with research conducted by Embrapa and universities such as USP and Unicamp.

Despite its potential, CRISPR raises ethical concerns, particularly regarding human germline editing, which can be hereditary. Off-target effects and the possibility of genetic mosaicism remain technical challenges. Regulations vary worldwide: in Brazil, CTNBio sets rules for genetically edited organisms, distinguishing them from transgenics.

The technology continues to evolve with variants like CRISPR-Cas12 and Cas13, expanding applications to disease diagnosis and RNA editing. CRISPR is not just a tool but an entire research field poised to transform biology and medicine in the coming decades.

Frequently Asked Questions

What is CRISPR?

CRISPR is a gene editing technology that allows precise cutting and modification of DNA. It was developed from a bacterial defense system and is widely used in research, medicine, and agriculture.

What are the medical applications of CRISPR?

Applications include treatment of genetic diseases like sickle cell disease and beta-thalassemia, cancer therapies, and development of new approaches for viral diseases. The first treatment, Casgevy, was approved in 2023.

Is CRISPR safe?

Safety depends on the context. Off-target effects and unintended editing are risks. Rigorous clinical trials and regulations like those from CTNBio in Brazil aim to ensure safety, but technical and ethical challenges remain.